Prevention and control measures of the major cold-region diseases (hypertension) in China

Zhenwei Pan; Yong Zhang; Tengfei Pan; Haihai Liang; Baofeng Yang

doi:10.2478/fzm-2021-0002

Prevention and control measures of the major cold-region diseases (hypertension) in China

doi: 10.2478/fzm-2021-0002

1.
Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy, Harbin Medical University, Harbin 150086, China
2.
Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences, China, 2019RU070

More Information

Corresponding author: Baofeng Yang, E-mail: yangbf@ems.hrbmu.edu.cn

摘要

Abstract: Hypertension is the most common cardiovascular condition in clinical practice and a major risk factor for stroke and cardiovascular events. There are more than 270 million hypertension patients in China, and the prevalence of hypertension in the high-latitude cold areas is significantly higher than in the low-latitude warm areas. The unique epidemiological characteristics and risk factors of hypertension in the cold regions of China urge for establishment of the prevention and control system for targeted and more effective management of the condition.
- hypertension /
- cold region /
- prevention /
- cure

HTML全文

参考文献(37)

[1]	Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal, 2018;39(33): 3021-3104. doi: 10.1093/eurheartj/ehy339
[2]	London G, Safar M, Weiss Y, et al. Volume-dependent parameters in essential hypertension. Kidney international, 1977;11(3): 204-208. doi: 10.1038/ki.1977.29
[3]	Mills K, Bundy J, Kelly T, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation, 2016;134(6): 441-450. doi: 10.1161/CIRCULATIONAHA.115.018912
[4]	Kearney P, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet (London, Engla nd), 2005;365(9455): 217-223. doi: 10.1016/S0140-6736(05)17741-1
[5]	Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet (London, England), 2017;390(10112): 2549-2558. doi: 10.1016/S0140-6736(17)32478-9
[6]	China TWCotRoCHDi. Summary of cardiovascular health and disease report 2019 in China. Chinese Circulation Journal, 2020;35(9): 833-854.
[7]	Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. Journal of Hypertension, 2008;26(7): 1477-1486. doi: 10.1097/HJH.0b013e3282fe1d3d
[8]	Gorelick P, Qureshi S, Farooq M. Management of blood pressure in stroke. International Journal of Cardiology Hypertension, 2019;3: 100021. doi: 10.1016/j.ijchy.2019.100021
[9]	Gaddam K, Verma A, Thompson M, et al. Hypertension and cardiac failure in its various forms. The Medical clinics of North America, 2009;93(3): 665-680. doi: 10.1016/j.mcna.2009.02.005
[10]	Hung G, Gu D, Wu X, et al. The influence of parental history of hypertension on the prevalence of hypertension and blood pressure in children. Chinese Journal of Hypertension, 2002(3): 81-84.
[11]	Buendia J, Bradlee M, Daniels S, et al. Longitudinal effects of dietary sodium and potassium on blood pressure in adolescent girls. JAMA pediatrics, 2015;169(6): 560-568. doi: 10.1001/jamapediatrics.2015.0411
[12]	Forman J, Stampfer M, Curhan G. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA, 2009;302(4): 401-411. doi: 10.1001/jama.2009.1060
[13]	Page M. The JNC 8 hypertension guidelines: an in-depth guide. The American Journal of Managed Care, 2014;20: E8. http://europepmc.org/abstract/med/25618230
[14]	Polonia J, Martins L, Pinto F, et al. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. Journal of Hypertension, 2014;32(6): 1211-1221. doi: 10.1097/HJH.0000000000000162
[15]	Carey R, Whelton P. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Annals of Internal Medicine, 2018;168(5): 351-358. doi: 10.7326/M17-3203
[16]	Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology, 2019;26(8): 824-835. doi: 10.1177/2047487318825350
[17]	Krist A, Davidson K, Mangione C, et al. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA, 2020;324(20): 2069-2075. doi: 10.1001/jama.2020.21749
[18]	Smith S, Wallace E, O'Dowd T, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. The Cochrane Database of Systematic Reviews, 2021;1: CD006560. http://www.journalslibrary.nihr.ac.uk/downloads/other-nihr-research/cochrane-programme-grants/Interventions-for-improving-outcomes-in-patients-with.pdf
[19]	Chobanian A, Bakris G, Black H, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 003;289(19): 2560-2572.
[20]	Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal, 2013;34(28): 2159-2219. doi: 10.1093/eurheartj/eht151
[21]	Brennan P, Greenberg G, Miall W, et al. Seasonal variation in arterial blood pressure. British medical journal (Clinical research ed), 1982;285(6346): 919-923. doi: 10.1136/bmj.285.6346.919
[22]	Brook R, Weder A, Rajagopalan S. "Environmental hypertensionology" the effects of environmental factors on blood pressure in clinical practice and research. Journal of Clinical Hypertension (Greenwich, Conn), 2011;13(11): 836-842. doi: 10.1111/j.1751-7176.2011.00543.x
[23]	Matsumoto M, Ishikawa S, Kajii E. Cumulative effects of weather on stroke incidence: a multi-community cohort study in Japan. Journal of Epid emiology, 2010;20(2): 136-142. http://www.jstage.jst.go.jp/article/jea/20/2/20_JE20090103/_pdf
[24]	Bhatnagar A. Environmental Determinants of Cardiovascular Disease. Circulation Research, 2017;121(2): 162-180. doi: 10.1161/CIRCRESAHA.117.306458
[25]	Lewington S, Li L, Sherliker P, et al. Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank. Journal of Hypertensi on, 2012;30(7): 1383-1391. doi: 10.1097/HJH.0b013e32835465b5
[26]	Manfredini R, Gallerani M, Portaluppi F, et al. Chronobiological patterns of onset of acute cerebrovascular diseases. Thrombosis Research, 1997;88(6): 451-463. doi: 10.1016/S0049-3848(97)00286-7
[27]	Sun Z. Cardiovascular responses to cold exposure. Frontiers in bioscience (Elite edition), 2010;2: 495-503. http://www.onacademic.com/detail/journal_1000040901211710_dd6c.html
[28]	Sun Z, Cade R, Zhang Z, et al. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension (Dallas, Tex: 1979), 2003;41(2): 322-327. doi: 10.1161/01.HYP.0000050964.96018.FA
[29]	Forsdyke D. Summertime dosage-dependent hypersensitivity to an angiotensin Ⅱ receptor blocker. BMC research notes, 2015;8: 227. doi: 10.1186/s13104-015-1215-8
[30]	Hong Y, Kim H, Lim Y, et al. Identification of RAS genotypes that modulate blood pressure change by outdoor temperature. Hypertension research: official journal of the Japanese Society of Hypertensi on, 2013;36(6): 540-545. doi: 10.1038/hr.2012.218
[31]	Shechtman O, Fregly M, van Bergen P, et al. Prevention of cold-induced increase in blood pressure of rats by captopril. Hypertension (Dallas, Tex: 1979), 1991;17: 763-770. doi: 10.1161/01.HYP.17.6.763
[32]	Song X. Study on the relationship between dietary nutrition and hypertension. China Health Industry, 2014;11(25): 22-23.
[33]	Tong S, Zhou L, Zhang H, et al. Meta-analysis of the prevalence of hypertension in cold and non-cold areas of China. Chinese Journal of End emiology, 2018;37(05): 420-425.
[34]	Li D, Lv J, Liu F, et al. Hypertension burden and control in mainland China: Analysis of nationwide data 2003-2012. International Journal of Cardiology, 2015;184: 637-644. doi: 10.1016/j.ijcard.2015.03.045
[35]	Yan S C, Zhou X, Jin L, et al. Prevalence, awareness and control of hypertension among adults in Heilongjiang Province in 2015. Chinese Journal of Public Health Management, 2019;35(06): 749-752.
[36]	Li H, Wu Z, Hui X, et al. Impact of local health insurance schemes on primary care management and control of hypertension: a cross-sectional study in Shenzhen, China. BMJ Open. 2019;9(10): e031098. doi: 10.1136/bmjopen-2019-031098
[37]	Zhao Y, Mahal A, Tang S, et al. Effective coverage for hypertension treatment among middle-aged adults and the older population in China, 2011 to 2013: A nationwide longitudinal study. Journal of Global Health. 2020;10(1): 010805. doi: 10.7189/jogh.10.010805